Image for Voyager Clinical Trial


A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).

Location Description

The Oscar Lambret Center is a private health facility of collective interest (ESPIC). It is based on several fundamental values: A multidisciplinary approach, medical progress, and attention to the patient.

Lille, France Clinical Trial Location

Centre Oscar Lambret
3 Rue Frédéric Combemale,
59000 Lille, France